Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $2,290 - $2,910
-10 Reduced 1.12%
882 $231,000
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $2,244 - $2,531
10 Added 1.13%
892 $201,000
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $373,519 - $415,662
-1,619 Reduced 64.73%
882 $215,000
Q1 2022

May 05, 2022

BUY
$219.27 - $242.57 $548,394 - $606,667
2,501 New
2,501 $605,000
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $8.07 Million - $9.46 Million
-48,406 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $536,822 - $605,115
2,968 Added 6.53%
48,406 $9.2 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $4.5 Million - $5.26 Million
-25,243 Reduced 35.71%
45,438 $8.85 Million
Q3 2018

Nov 05, 2018

BUY
$185.29 - $208.89 $755,242 - $851,435
4,076 Added 6.12%
70,681 $14.7 Million
Q2 2018

Jul 25, 2018

SELL
$166.05 - $186.51 $127,194 - $142,866
-766 Reduced 1.14%
66,605 $12.3 Million
Q1 2018

May 08, 2018

BUY
$169.43 - $198.0 $84,545 - $98,802
499 Added 0.75%
67,371 $11.5 Million
Q4 2017

Feb 05, 2018

BUY
$168.79 - $188.59 $281,035 - $314,002
1,665 Added 2.55%
66,872 $11.6 Million
Q3 2017

Oct 16, 2017

BUY
$167.29 - $191.0 $10.9 Million - $12.5 Million
65,207
65,207 $12.2 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Main Street Research LLC Portfolio

Follow Main Street Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Research LLC with notifications on news.